Trial intelligence / Profile preview

Microcept, Progest, and Ponstan Forte for Heavy Menstrual Bleeding

NCT02943655Phase 3Completed

Sponsor
Assiut University
Start
Nov 2017
Primary completion
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ethinylestradiol + levonorgestrel, progesterone, Mefenamic acid in Heavy menstrual bleeding, sponsored by Assiut University. Started Nov 2017; status: completed.

02

Drugs

ethinylestradiol + levonorgestrelprogesteroneMefenamic acid
03

Conditions

Heavy menstrual bleeding

Beyond the preview

Go deeper on NCT02943655.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02943655.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call